Hong Huang Selected Research

Antirheumatic Agents (DMARD)

1/2021	Dynamical trajectory of glucocorticoids tapering and discontinuation in patients with rheumatoid arthritis commencing glucocorticoids with csDMARDs: a real-world data from 2009 to 2020.
10/2020	Risk of malignancy with non-TNFi biologic or tofacitinib therapy in rheumatoid arthritis: A meta-analysis of observational studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hong Huang Research Topics

Disease

29	Neoplasms (Cancer) 01/2022 - 04/2002
21	Inflammation (Inflammations) 03/2022 - 05/2007
9	Hypoxia (Hypoxemia) 05/2022 - 01/2003
9	Wounds and Injuries (Trauma) 04/2020 - 02/2012
8	Insulin Resistance 06/2022 - 08/2011
8	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2003
6	Rheumatoid Arthritis 11/2022 - 10/2020
6	Cognitive Dysfunction 03/2022 - 03/2016
6	Fibrosis (Cirrhosis) 01/2021 - 11/2003
6	Aggressive Periodontitis (Periodontosis) 11/2020 - 01/2013
5	Neuroinflammatory Diseases 01/2022 - 01/2020
5	Infections 01/2022 - 05/2006
5	Type 2 Diabetes Mellitus (MODY) 11/2021 - 04/2010
5	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 04/2010
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2016 - 08/2009
4	Carcinogenesis 01/2022 - 04/2002
4	Adenocarcinoma of Lung 01/2022 - 01/2003
4	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 02/2007
4	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 10/2014
4	Hyperglycemia 01/2019 - 08/2009
4	Lung Injury 01/2017 - 10/2003
4	Hypercapnia 11/2006 - 05/2004
3	Body Weight (Weight, Body) 06/2022 - 01/2016
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2020
3	Sepsis (Septicemia) 01/2021 - 05/2006
3	Necrosis 10/2020 - 03/2003
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2020 - 03/2005
3	Birth Weight (Birth Weights) 10/2018 - 05/2014
2	Obesity 06/2022 - 01/2021
2	Overweight 06/2022 - 01/2016
2	Mental Disorders (Mental Disorder) 05/2022 - 10/2021
2	Osteoporosis 05/2022 - 12/2003
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2022 - 10/2021
2	Arthritis (Polyarthritis) 01/2022 - 02/2007
2	Pneumonia (Pneumonitis) 01/2022 - 08/2006
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 09/2017
2	Acquired Hyperostosis Syndrome (SAPHO Syndrome) 01/2022 - 03/2021
2	Pain (Aches) 11/2021 - 01/2014
2	Obstructive Sleep Apnea 01/2021 - 08/2012
2	Pathologic Constriction (Stenosis) 01/2021 - 12/2020
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 07/2003
2	Atherosclerosis 01/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2002
15	Biomarkers (Surrogate Marker)IBA 11/2022 - 04/2002
8	Messenger RNA (mRNA)IBA 07/2019 - 05/2004
7	CytokinesIBA 11/2020 - 06/2005
7	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 08/2011
7	CollagenIBA 05/2017 - 11/2003
6	C-Reactive ProteinIBA 04/2022 - 09/2012
6	Pharmaceutical PreparationsIBA 01/2022 - 12/2009
6	Biological ProductsIBA 01/2021 - 11/2003
5	Insulin (Novolin)FDA Link 06/2022 - 01/2012
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2003
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 06/2005
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 01/2017
4	Sirtuin 1IBA 01/2022 - 10/2019
4	Indicators and Reagents (Reagents)IBA 01/2022 - 11/2003
4	LipopolysaccharidesIBA 01/2020 - 06/2005
4	EnzymesIBA 01/2015 - 05/2008
3	Toll-Like Receptor 4IBA 03/2022 - 06/2005
3	Interleukin-6 (Interleukin 6)IBA 03/2022 - 01/2016
3	Liposomes (Liposome)IBA 01/2022 - 05/2004
3	Superoxide DismutaseIBA 01/2022 - 11/2003
3	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021 - 01/2020
3	Tobacco Smoke Pollution (Passive Smoking)IBA 09/2019 - 01/2015
3	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 06/2008
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2017 - 01/2016
3	Streptozocin (Streptozotocin)FDA Link 03/2017 - 08/2009
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016 - 02/2012
3	Therapeutic UsesIBA 01/2016 - 12/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2015 - 06/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2015 - 08/2009
3	trichostatin A (A 300)IBA 01/2015 - 09/2003
3	theasinensin AIBA 01/2015 - 01/2003
3	Pattern Recognition ReceptorsIBA 05/2006 - 06/2005
2	GlucocorticoidsIBA 04/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 12/2013
2	NF-kappa B (NF-kB)IBA 03/2022 - 01/2020
2	AntibodiesIBA 03/2022 - 04/2020
2	Malondialdehyde (Propanedial)IBA 01/2022 - 10/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 04/2002
2	Hematoxylin (Haematoxylon)IBA 01/2022 - 01/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 01/2017
2	tofacitinibIBA 01/2022 - 10/2020
2	oxidized low density lipoproteinIBA 01/2021 - 01/2017
2	SolutionsIBA 01/2021 - 01/2016
2	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2020
2	Lipoproteins (Lipoprotein)IBA 01/2021 - 06/2005
2	Scopolamine (Hyoscine)FDA Link 01/2021 - 01/2021
2	Sucrose (Saccharose)IBA 01/2021 - 01/2019
2	Neuroprotective AgentsIBA 01/2021 - 06/2016
2	LipidsIBA 01/2021 - 10/2017
2	Immune Checkpoint InhibitorsIBA 01/2021 - 12/2020
2	EndotoxinsIBA 01/2021 - 10/2003
2	Prednisone (Sone)FDA LinkGeneric 01/2021 - 12/2003
2	Antirheumatic Agents (DMARD)IBA 01/2021 - 10/2020

Therapy/Procedure

28	Therapeutics 04/2022 - 09/2003
4	Ligation 01/2021 - 12/2011
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2021